← Evidence map

ArticleHeliyon2025

Corrigendum to "Towards targeted cancer therapy: synthesis, characterization, and biological activity of a new Cu(II)-ibuprofen-2,2'-dipyridylamine metal complex" [Heliyon Volume 11, Issue 1, January 2025, Article e41323].

Luís P G Monteiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "Towards targeted cancer therapy: synthesis, characterization, and biological activity of a new Cu(II)-ibuprofen-2,2'-dipyridylamine metal complex" [Heliyon Volume 11, Issue 1, January 2025, Article e41323]. | OpenQuestion